New publications

A paper by Shu, a former student I supervised, has been released. Congratulations!

We demonstrated that by modifying the chemical structure of polysaccharide derivatives with adjuvant activity and conjugating them to proteins, it is possible to induce a strong anti-cancer immune response.

By changing the protein used for conjugation, this approach is expected to lead to therapeutic systems that can induce cancer-specific immune responses.

[Publication Information] (Open Access)

X. Shu, E. Yuba,  Spacer-engineered carboxylated curdlan derivatives for dendritic cell activation and cancer immunotherapy, OpenNano., 28, 100289 (2026).